Literature DB >> 4963785

Preparation and effect of different adjuvants on the immunogenic activity of mycobacterial ribosomal fraction.

A S Youmans, G P Youmans.   

Abstract

Several emulsified and two nonemulsified incomplete adjuvants were examined for their adjuvant activity by use of mycobacterial ribosomal fractions as a substrate. A good adjuvant is defined as one which produces a high immunological response with the ribosomal fraction in mice to infection with virulent tubercle bacilli. Freund's incomplete adjuvant, consisting of Aquaphor and heavy mineral oil, and Arlacel A plus hexadecane were the best adjuvants tested. Aquaphor plus light mineral oil and Arlacel A plus 7-n-hexyloctadecane were not quite as effective. Peanut oil was not satisfactory when emulsified with either Aquaphor or Arlacel A. A moderate degree of immunity was produced in mice vaccinated with ribosomal fraction mixed with aluminum hydroxide gel. Sodium alginate mixed with ribosomal fraction produced a low degree of immunity only with the highest vaccinating dose. It was found that the effectiveness of the emulsified type of adjuvant depended upon the method of preparation. Careful standardization of technique to produce uniform and complete emulsification was essential for maximal adjuvant activity using minimal vaccinating doses. A rapid and practical method of preparing emulsified adjuvants is given. The mode of action of incomplete adjuvants as employed in these experiments is discussed, and it is thought that they acted primarily by protecting the ribosomes from being inactivated by host ribonuclease before they were engulfed by the macrophages.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4963785      PMCID: PMC276741          DOI: 10.1128/jb.94.4.836-843.1967

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  18 in total

Review 1.  A FORWARD LOOK AT VIRAL VACCINES: WITH SPECIAL REFERENCE TO A NEW IMMUNOLOGIC ADJUVANT.

Authors:  M R HILLEMAN
Journal:  Am Rev Respir Dis       Date:  1964-11

2.  THE EFFECT OF ADJUVANTS ON A NONVIABLE ANTITUBERCULOSIS VACCINE AND ON LIVE BCG.

Authors:  A HOYT; M A THOMPSON; F J MOORE; C R SMITH
Journal:  Am Rev Respir Dis       Date:  1965-04

3.  ON THE MECHANISM OF ADJUVANT ACTION OF NONSPECIFIC STIMULATORS OF ANTIBODY FORMATION.

Authors:  I Y UCHITEL; E L KHASMAN
Journal:  J Immunol       Date:  1965-04       Impact factor: 5.422

4.  Blood nucleases and infectious viral nucleic acids.

Authors:  R M HERRIOTT; J H CONNOLLY; S GUPTA
Journal:  Nature       Date:  1961-03-11       Impact factor: 49.962

5.  Studies on the mechanism of action of emulsified vaccines.

Authors:  R W MCKINNEY; F M DAVENPORT
Journal:  J Immunol       Date:  1961-01       Impact factor: 5.422

6.  Ribonuclease. I. A new assay method with P32 labeled yeast ribonucleic acid.

Authors:  J S ROTH; S W MILSTEIN
Journal:  J Biol Chem       Date:  1952-05       Impact factor: 5.157

7.  An examination of "transfer of learning" by nucleic Acid.

Authors:  M Luttges; T Johnson; C Buck; J Holland; J McGaugh
Journal:  Science       Date:  1966-02-18       Impact factor: 47.728

8.  The metabolism of exogenous ribonucleic acids injected into mice.

Authors:  S Sved
Journal:  Can J Biochem       Date:  1965-07

9.  Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

10.  Infectivity of ribonucleic acid from poliovirus in human cell monolayers.

Authors:  H E ALEXANDER; G KOCH; I M MOUNTAIN; O VAN DAMME
Journal:  J Exp Med       Date:  1958-10-01       Impact factor: 14.307

View more
  23 in total

1.  Immuno-stimulation by a ribosomal vaccine associated with a bacterial cell wall adjuvant in humans.

Authors:  F B Michel; L Dussourd D'Hinterland; J Bousquet; A M Pinel; G Normier
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

Review 2.  Immunological properties of teichoic acids.

Authors:  K W Knox; A J Wicken
Journal:  Bacteriol Rev       Date:  1973-06

3.  Immunological studies on treponemal cellular antigens. I. Serological changes and resistance to infection in rabbits immunized with treponemal nucleic acids.

Authors:  N N Izzat; E Yazdi
Journal:  Br J Vener Dis       Date:  1973-08

4.  Immunizing capacity of viable and killed attenuated mycobacterial cells against experimental tuberculous infection.

Authors:  G P Youmans; A S Youmans
Journal:  J Bacteriol       Date:  1969-01       Impact factor: 3.490

5.  Factors affecting immunogenic activity of mycobacterial ribosomal and ribonucleic acid preparations.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1969-07       Impact factor: 3.490

6.  Relationship between tuberculin hypersensitivity and cellular immunity to infection in mice vaccinated with viable attenuated Mycobacterial cells or with Mycobacterial ribonucleic acid preparations.

Authors:  R G Neiburger; G P Youmans; A S Youmans
Journal:  Infect Immun       Date:  1973-07       Impact factor: 3.441

7.  Effect of rifampin on immunity to tuberculosis and on delayed hypersensitivity to purified protein derivative.

Authors:  A S Youmans; G P Youmans; D Cahall
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

8.  Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes.

Authors:  W O Schalla; W Johnson
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

9.  Immunogenic activity of a ribosomal fraction obtained from Pasteurella multocida.

Authors:  T Baba
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

10.  Humoral and cell-mediated responses to a ribosomal preparation from Streptococcus mutans.

Authors:  R L Gregory; I L Shechmeister
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.